In the past five years, research has found that GLP-1 drugs can lower the risk of a number of obesity-related chronic diseases such as heart disease, chronic kidney disease, sleep disorders, osteoarthritis and even certain cancers, with one study finding that people taking GLP-1 drugs had a lower risk of developing 42 different diseases than those given their usual medicines
Yes, semaglutide can indirectly enhance your sex life by promoting substantial weight loss, which may boost self-esteem, improve body image, and support better sexual function and hormonal health
Blood glucose self-monitoring is necessary to adjust the dose of sulfonylurea and insulin particularly when Semaglut is started and insulin is reduced
actual profiles were designed to directly replicate the efficacy and safety of a given GLP-1 RA therapy as seen in the PIONEER 9 and 10 trials, or averaged between the two trials (in the case of the oral semaglutide treatment profiles)
The goal is lasting change, not just temporary weight loss